Literature DB >> 20395010

Molecular diversity through RNA editing: a balancing act.

Sanaz Farajollahi1, Stefan Maas.   

Abstract

RNA editing by adenosine deamination fuels the generation of RNA and protein diversity in eukaryotes, particularly in higher organisms. This includes the recoding of translated exons, widespread editing of retrotransposon-derived repeat elements and sequence modification of microRNA (miRNA) transcripts. Such changes can bring about specific amino acid substitutions, alternative splicing and changes in gene expression levels. Although the overall prevalence of adenosine-to-inosine (A-to-I) editing and its specific functional impact on many of the affected genes is not yet known, the importance of balancing RNA modification levels across time and space is becoming increasingly evident. In particular, transcriptome instabilities in the form of too much or too little RNA editing activity, or misguided editing, manifest in several human disease phenotypes and can disrupt that balance. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395010      PMCID: PMC2865426          DOI: 10.1016/j.tig.2010.02.001

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  97 in total

1.  Dynamic association of RNA-editing enzymes with the nucleolus.

Authors:  Joana M P Desterro; Liam P Keegan; Miguel Lafarga; Maria Teresa Berciano; Mary O'Connell; Maria Carmo-Fonseca
Journal:  J Cell Sci       Date:  2003-05-01       Impact factor: 5.285

2.  Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss.

Authors:  Barmak Modrek; Christopher J Lee
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

Review 3.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

4.  Glutamate receptors: RNA editing and death of motor neurons.

Authors:  Yukio Kawahara; Kyoko Ito; Hui Sun; Hitoshi Aizawa; Ichiro Kanazawa; Shin Kwak
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

5.  Modulation of RNA editing by functional nucleolar sequestration of ADAR2.

Authors:  Christopher L Sansam; K Sam Wells; Ronald B Emeson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

6.  Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation.

Authors:  Jing-Hua Yang; Xiaoxing Luo; Yongzhan Nie; Yingjun Su; Qingchuan Zhao; Koroush Kabir; Dexin Zhang; Reuven Rabinovici
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

7.  Transcript mutations of the alpha regulatory subunit of protein kinase A and up-regulation of the RNA-editing gene transcript in lupus T lymphocytes.

Authors:  Dama Laxminarayana; Islam U Khan; Gary Kammer
Journal:  Lancet       Date:  2002-09-14       Impact factor: 79.321

8.  Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.

Authors:  Shogo Ishiuchi; Keisuke Tsuzuki; Yukari Yoshida; Nobuaki Yamada; Norikazu Hagimura; Haruo Okado; Akiko Miwa; Hideyuki Kurihara; Yoichi Nakazato; Masaru Tamura; Tomio Sasaki; Seiji Ozawa
Journal:  Nat Med       Date:  2002-08-12       Impact factor: 53.440

9.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

10.  Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1.

Authors:  Jochen C Hartner; Carolin Schmittwolf; Andreas Kispert; Albrecht M Müller; Miyoko Higuchi; Peter H Seeburg
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

View more
  90 in total

1.  In search of beneficial coding RNA editing.

Authors:  Guixia Xu; Jianzhi Zhang
Journal:  Mol Biol Evol       Date:  2014-11-12       Impact factor: 16.240

Review 2.  Biological significance of RNA editing in cells.

Authors:  Wei Tang; Yongjun Fei; Michael Page
Journal:  Mol Biotechnol       Date:  2012-09       Impact factor: 2.695

3.  Accurate identification of A-to-I RNA editing in human by transcriptome sequencing.

Authors:  Jae Hoon Bahn; Jae-Hyung Lee; Gang Li; Christopher Greer; Guangdun Peng; Xinshu Xiao
Journal:  Genome Res       Date:  2011-09-29       Impact factor: 9.043

4.  Extensive loss of RNA editing sites in rapidly evolving Silene mitochondrial genomes: selection vs. retroprocessing as the driving force.

Authors:  Daniel B Sloan; Alice H MacQueen; Andrew J Alverson; Jeffrey D Palmer; Douglas R Taylor
Journal:  Genetics       Date:  2010-05-17       Impact factor: 4.562

5.  Channels get in an HUFA: RNA editing gets them out of a jam.

Authors:  Richard Horn; Robert Reenan
Journal:  EMBO J       Date:  2010-07-07       Impact factor: 11.598

Review 6.  MicroRNAs in neurodegenerative diseases and their therapeutic potential.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

Review 7.  Functions and regulation of the APOBEC family of proteins.

Authors:  Harold C Smith; Ryan P Bennett; Ayse Kizilyer; William M McDougall; Kimberly M Prohaska
Journal:  Semin Cell Dev Biol       Date:  2011-10-06       Impact factor: 7.727

Review 8.  Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase.

Authors:  Jean-François Gélinas; Guerline Clerzius; Eileen Shaw; Anne Gatignol
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

9.  Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells.

Authors:  Yukti Choudhury; Felix Chang Tay; Dang Hoang Lam; Edwin Sandanaraj; Carol Tang; Beng-Ti Ang; Shu Wang
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

Review 10.  RNA-binding proteins in neurodegeneration: Seq and you shall receive.

Authors:  Julia K Nussbacher; Ranjan Batra; Clotilde Lagier-Tourenne; Gene W Yeo
Journal:  Trends Neurosci       Date:  2015-03-09       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.